Serum Cystatin 4 combined with routine clinical laboratory indicators: A support vector machine diagnostic model for early screening of gastrointestinal tumors
Huijuan Bi, Lina Yin, Wenhao Fang, Jilu Shen · 2026
Read Serum Cystatin 4 combined with routine clinical laboratory indicators: A support vector machine diagnostic model for early screening of gastrointestinal tumors by Huijuan Bi, Lina Yin, Wenhao Fang, Jilu Shen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353753.txt.
Description
Huijuan Bi and three colleagues build a blood test model to catch stomach and bowel tumors early, in PLOS ONE in 2026. Gastrointestinal tumors are usually found late, and single blood markers miss too much. The team compared two hundred fourteen patients with one hundred thirty tumor free controls across thirty-eight routine laboratory measures. They distilled seven core variables. Then they trained eleven machine learning algorithms to separate the groups.
One marker, serum cystatin 4, already stood higher in patients, though weak alone. The support vector machine model won the contest, scoring well on overall discrimination and catching over ninety-five percent of tumors, at the price of more false alarms among the healthy. An explanation analysis credited blood count, the cystatin marker, and age as the strongest inputs. The authors offer the model as an internally validated screening aid for high risk groups, pending outside testing.
Catalog record
| CREATOR | Huijuan Bi, Lina Yin, Wenhao Fang, Jilu Shen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39391 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |